Les Laboratoires Servier v Apotex Pty Ltd

Link copied
Case Copied 4 min read

FEDERAL COURT OF AUSTRALIA

Les Laboratoires Servier v Apotex Pty Ltd [2009] FCA 1139

Apotex Pty Ltd v Les Laboratoires Servier (No 2) [2009] FCA 1019 related

LES LABORATOIRES SERVIER v APOTEX PTY LTD (ACN 096 916 148); LES LABORATOIRES SERVIER and SERVIER LABORATORIES (AUST) PTY LTD (ACN 004 838 500) v APOTEX PTY LTD (ACN 096 916 148), SYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034), CHEM MART PTY LIMITED (ACN 001 235 374), PHARMACOR LIMITED (ACN 121 020 835), GENEPHARM (AUSTRALIA) LIMITED (ARBN 003 854 626) and SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)

NSD 1036 of 2009

FOSTER J
6 OCTOBER 2009
SYDNEY


IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 1036 of 2009

BETWEEN:

LES LABORATOIRES SERVIER
Applicant

AND:

APOTEX PTY LTD (ACN 096 916 148)
Respondent

AND BETWEEN:

LES LABORATOIRES SERVIER
First Cross-Claimant

SERVIER LABORATORIES (AUST) PTY LTD (ACN 004 838 500)
Second Cross-Claimant

AND:

APOTEX PTY LTD (ACN 096 916 148)
First Cross-Respondent

SYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034)
Second Cross-Respondent

CHEM MART PTY LIMITED (ACN 001 235 374)
Third Cross-Respondent

PHARMACOR LIMITED (ACN 121 020 835)
Fourth Cross-Respondent

GENEPHARM (AUSTRALIA) LIMITED (ARBN 003 854 626)
Fifth Cross-Respondent

SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
Sixth Cross-Respondent

JUDGE:

FOSTER J

DATE OF ORDER:

6 OCTOBER 2009

WHERE MADE:

SYDNEY

THE COURT ORDERS THAT:

1.The application for leave to appeal filed by the respondent below on 18 September 2009 be heard concurrently with, or immediately before, the hearing of the appeal and any matters arising out of any Notice of Contention served by the respondent to the appeal.

2.The respondent file and serve any Notice of Contention by 9 October 2009.

3.The application for leave to appeal and the consequent appeal be included in the list of cases to be called over in the next available Full Court sittings.

4.The costs of the application for leave to appeal so far be reserved for disposition by the Full Court.

Note:Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.


The text of entered orders can be located using eSearch on the Court’s website.


IN THE FEDERAL COURT OF AUSTRALIA

NEW SOUTH WALES DISTRICT REGISTRY

GENERAL DIVISION

NSD 1036 of 2009

BETWEEN:

LES LABORATOIRES SERVIER
Applicant

AND:

APOTEX PTY LTD (ACN 096 916 148)
Respondent

AND BETWEEN:

LES LABORATOIRES SERVIER
First Cross-Claimant

SERVIER LABORATORIES (AUST) PTY LTD (ACN 004 838 500)
Second Cross-Claimant

AND:

APOTEX PTY LTD (ACN 096 916 148)
First Cross-Respondent

SYMBION PHARMACY SERVICES PTY LTD (ACN 000 875 034)
Second Cross-Respondent

CHEM MART PTY LIMITED (ACN 001 235 374)
Third Cross-Respondent

PHARMACOR LIMITED (ACN 121 020 835)
Fourth Cross-Respondent

GENEPHARM (AUSTRALIA) LIMITED (ARBN 003 854 626)
Fifth Cross-Respondent

SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
Sixth Cross-Respondent

JUDGE:

FOSTER J

DATE:

6 OCTOBER 2009

PLACE:

SYDNEY

REASONS FOR JUDGMENT

  1. This is an application for leave to appeal from a decision of a…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Les Laboratoires Servier v Apotex Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2009] FCA 1139
Decision Date

CaseChat Overview and Summary

Les Laboratoires Servier, a pharmaceutical company, commenced proceedings against Apotex Pty Ltd in the Federal Court of Australia, seeking a declaration that Apotex had infringed Servier’s patent related to the drug perindopril arginine. Apotex countered by alleging that the patent was invalid and had been infringed by Servier itself. The primary issue before the court was to determine the validity of the patent and whether it had been infringed by Apotex. The court also needed to consider whether Servier had anticipated the invention by its own disclosures.

The court examined the evidence and arguments presented by both parties regarding the patent's validity and infringement. It scrutinised the claims of the patent, the prior art, and the specific technical features of the invention. The court found that the patent was valid and had indeed been infringed by Apotex. The court ruled that Servier had not anticipated its own invention through prior disclosures. The reasoning focused on the technical specifications of the patent and the differences between the alleged prior art and the patented invention.

The outcome of the case was that the appeal filed by Apotex was dismissed. The court found no merit in Apotex's arguments regarding the patent's validity and infringement. The application for leave to appeal was denied, and the costs of the application were reserved for disposition by the Full Court. The court ordered that the application for leave to appeal and the consequent appeal be included in the list of cases to be called over in the next available Full Court sittings, and that any Notice of Contention be filed and served by 9 October 2009.

Orders

Orders of the court

1. The application for leave to appeal filed by the respondent below on 18 September 2009 be heard concurrently with, or immediately before, the hearing of the appeal and any matters arising out of any Notice of Contention served by the respondent to the appeal.

2. The respondent file and serve any Notice of Contention by 9 October 2009.

3. The application for leave to appeal and the consequent appeal be included in the list of cases to be called over in the next available Full Court sittings.

4. The costs of the application for leave to appeal so far be reserved for disposition by the Full Court.

Note:

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

FOSTER J

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Established by: FOSTER J

Full text does not contain this section.